Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin
Objective: A major site of action for the atheroprotective drug nicotinic acid (NA) is adipose tissue, via the G-protein-coupled receptor, GPR109A. Since, adipose tissue is an active secretory organ that contributes both positively and negatively to systemic inflammatory processes associated with ca...
Main Authors: | Digby, J, McNeill, E, Dyar, O, Lam, V, Greaves, DR, Choudhury, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin.
by: Digby, J, et al.
Published: (2010) -
Anti-inflammatory Effects of Nicotinic Acid: Suppression of Fractalkine, RANTES, and MCP-1 and Upregulation of Adiponectin in 3T3-L1 Adipocytes
by: Digby, J, et al.
Published: (2008) -
Fractalkine promotes human monocyte survival via a reduction in oxidative stress.
by: White, G, et al.
Published: (2014) -
Fractalkine: one chemokine, many functions.
by: White, G, et al.
Published: (2009) -
Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators.
by: White, G, et al.
Published: (2012)